Empowering Patients' Lung Cancer Screening Uptake
- Conditions
- Lung Cancer
- Interventions
- Behavioral: Patient educationBehavioral: Referral to financial navigation resourcesBehavioral: Patient RemindersBehavioral: Provider Reminers
- Registration Number
- NCT06000683
- Lead Sponsor
- University of California, Irvine
- Brief Summary
Lung cancer is the leading cause of cancer related mortality. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases mortality rate of lung cancer by 20%. Yet many patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test the effect of a a multi-level intervention on ordering LDCT within 6 months after patient enrollment. Our proposed intervention includes (1) Primary care provider notifications of patients' LCS eligibility; (2) patients' education ; (3) patients' referral to financial navigation resources; and (4) patients' reminder to discuss LCS during PCP visit.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 70
- Aged 50- 80 years of age.
- Be able to Speak English, Spanish, or Vietnamese
- Must have a scheduled appointment with their Primary Care Providers within next one to three months.
- The Scheduled PCP appointment is at any of the UCI Health primary care clinics in Orange County including two UCI federally qualified health centers
- History of 20 pack year smoking history ( based on survey self report)
- Current smoker or a former smoker who has quit smoking within the last 15 years (based on survey self report)
- Prior history of lung cancer
- chest CT for any reason in the last 12 months based on self-report and UCI EMR
- history of Alzheimer's disease or dementia
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Empower LCS Patient education Patient will be given education material(addressing knowledge barriers); patients' referral to financial navigation resources (addressing health-related social risks); and patients' reminder to discuss LCS during PCP visit. Providers will also be notified of eligibility of their patients to receive LCS. Empower LCS Patient Reminders Patient will be given education material(addressing knowledge barriers); patients' referral to financial navigation resources (addressing health-related social risks); and patients' reminder to discuss LCS during PCP visit. Providers will also be notified of eligibility of their patients to receive LCS. Empower LCS Provider Reminers Patient will be given education material(addressing knowledge barriers); patients' referral to financial navigation resources (addressing health-related social risks); and patients' reminder to discuss LCS during PCP visit. Providers will also be notified of eligibility of their patients to receive LCS. Empower LCS Referral to financial navigation resources Patient will be given education material(addressing knowledge barriers); patients' referral to financial navigation resources (addressing health-related social risks); and patients' reminder to discuss LCS during PCP visit. Providers will also be notified of eligibility of their patients to receive LCS.
- Primary Outcome Measures
Name Time Method Order of LDCT within 6 months of enrollment Primary end point is order of LDCT within 6 months after enrollment assessed with self-reported surveys and EMR data extraction.
- Secondary Outcome Measures
Name Time Method Perceived Risk of lung cancer at baseline and 6 month post enrollment self reported in survey
Perceived Severity of lung cancer at baseline and 6 month post enrollment self reported in survey
Perceived barriers lung cancer screening at baseline and 6 month post enrollment self reported in survey
Perceived Benefit of lung cancer screening at baseline and 6 month post enrollment self reported in survey
Providers' Perceived barriers within 3 month after last patient enrolled Provider will be asked about perceived barriers and knowledge of Lung cancer screening though a survey
Self-efficacy for lung cancer screening at baseline and 6 month post enrollment self reported in survey
Receipt of LDCT Within 6 months of enrollment A receipt of LDCT for LCS will be checked either through self reported or EMR
Knowledge about lung cancer and screening at baseline and 6 month post enrollment self reported in survey
LCS discussion within 6 months after enrollment Patient and Primary Care Provider discussing lung cancer screening
Trial Locations
- Locations (7)
UCI Health - Costa Mesa
🇺🇸Costa Mesa, California, United States
UCI Health Gottschalk Medical Plaza
🇺🇸Irvine, California, United States
UCI Health - Laguna Hills
🇺🇸Laguna Hills, California, United States
UCI Health - Newport Beach MacArthur
🇺🇸Newport Beach, California, United States
UCI Medical Center
🇺🇸Orange, California, United States
UCI Health - Tustin
🇺🇸Tustin, California, United States
UCI Health-Yorba Linda
🇺🇸Yorba Linda, California, United States